Related Experiment Video
Updated: Jan 29, 2026

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
Published on: January 10, 2025
Sodium channel blockers as add-on treatment for unexplained refractory chronic cough: a case report and review
I Butnariu1,2, M-F Balan2, D C Zaharia3,4
1Department of Clinical Neurosciences, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Introduction:
Chronic cough is a common symptom with multiple causes, predominantly respiratory, gastroesophageal, or neurological. However, in rare cases, a vascular anomaly, such as internal jugular vein ectasia (IJVE), may function as a trigger. We report the case of a patient with paroxysmal chronic cough associated with right internal jugular vein ectasia, which responded favorably to anticonvulsant therapy.
Case Report:
We present the case of a 62-year-old female patient with pulmonary, cardiovascular, and neurological comorbidities, with a two-year history of daily episodes of severe, non-productive cough, refractory to standard symptomatic treatments. ENT, pulmonary, and gastroenterological evaluations did not identify a specific organic cause. The neurological examination was unremarkable, with no cranial nerve deficits. Cervical CT with contrast revealed a fusiform right internal jugular vein ectasia (IJVE) (area of 2.11 cm2 compared to the left side, 0.50 cm2). A chronic neurogenic cough possibly linked to the IJVE was suspected, and treatment with carbamazepine (300 mg three times daily) and codeine (15 mg four times daily) was successful in near-complete cough suppression.
Conclusion:
This case adds to the emerging evidence regarding a possible link between IJVE and chronic neuropathic cough. Although rare, this etiology should be considered in chronic cough syndromes without an apparent cause. Neuropathic cough is underdiagnosed and may benefit from anticonvulsant treatment, while the identification of atypical mechanisms requires a multidisciplinary approach.
Related Concept Videos
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of Calcium Channel Blockers

